Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Biju Mohamed"'
Publikováno v:
BMJ Open Quality, Vol 9, Iss 3 (2020)
Background To develop an effective, patient-centred and sustainable service, we set up a virtual clinic (VC) for patients with Parkinson’s disease, combining phone consultations and reports from wearable technology. The Parkinson’s Kinetigraph (P
Externí odkaz:
https://doaj.org/article/24f2425925f34631b6a53d047776e71e
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 12 (2019)
Sialorrhoea is a frequent symptom of neurological diseases (e.g. Parkinson’s disease, motor neuron disease, cerebral palsy, and stroke) and is defined as excessive saliva accumulation leading to unintentional loss of saliva from the mouth. Sialorrh
Externí odkaz:
https://doaj.org/article/930ccbe4799741a2855bfa01b0db851d
Publikováno v:
Clinical Psychology Forum. 1:20-28
Despite the substantial body of literature supporting the knowledge base of Parkinson’s disease more generally, there is comparably limited awareness and knowledge of the psychological impact of the condition. More recent literature has emphasised
Publikováno v:
Age and Ageing
Introduction A timely diagnosis of dementia is crucial for initiating and maintaining support for people living with dementia. The coronavirus disease (COVID) pandemic temporarily halted Memory Clinics, where this is organised, and rate of dementia d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aefa9e2359fcbc8de0c63df864222831
Autor:
Biju Mohamed, Svetlana Kalabina, Jonathan Belsey, Brian Paterson, Dominic Pivonka, Chris Thomas
Publikováno v:
Journal of Medical Economics. 22:215-225
To carry out a cost-utility analysis comparing the cost-effectiveness of levodopa carbidopa intestinal gel (LCIG) with standard of care (SOC) in patients with advanced Parkinson's Disease (aPD) unsuitable for apomorphine or deep brain stimulation (DB
Publikováno v:
Progress in Neurology and Psychiatry. 22:11-14
Autor:
Heinz Reichmann, Diogo Martins, Biju Mohamed, Patrício Soares-da-Silva, Andrew J. Lees, Diogo Magalhães, José Rocha
Publikováno v:
Journal of the Neurological Sciences. 429:119431
Supplemental material, APPROVED_Xeomin_Prescribing_information_UKIE_combined_June_2019_v4 for The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin®) by Francesca Morgante
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06a0bb4843358bd5559404f5bf762a37
Publikováno v:
Therapeutic Advances in Neurological Disorders
Therapeutic Advances in Neurological Disorders, Vol 12 (2019)
Therapeutic Advances in Neurological Disorders, Vol 12 (2019)
Sialorrhoea is a frequent symptom of neurological diseases (e.g. Parkinson’s disease, motor neuron disease, cerebral palsy, and stroke) and is defined as excessive saliva accumulation leading to unintentional loss of saliva from the mouth. Sialorrh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11d1304714d0a1d0baa0a8e1a22d04c7
http://hdl.handle.net/11570/3168421
http://hdl.handle.net/11570/3168421
Autor:
Donald G. Grosset, Kallol Ray Chaudhuri, Papari Prashanth Reddy, Miriam Parry, Camille Carroll, Biju Mohamed, Robin Fackrell, Thomas Foltynie
Publikováno v:
King's College London
In the past 4 years, two adjunctive treatment options to levodopa have been licensed for use in the UK in patients with Parkinson's disease (PD) and motor fluctuations: opicapone, a third-generation catechol-O-methyl transferase inhibitor, and safina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f613317be04ef1edd8af5e88d20b1777
https://eprints.gla.ac.uk/191370/1/191370.pdf
https://eprints.gla.ac.uk/191370/1/191370.pdf